Dr. Casadevall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Weiler Dept of Medicine
1825 Eastchester Road
Bronx, NY 10461Phone+1 718-430-3659Fax+1 718-430-8968
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 1988 - 1991
NYU Grossman School of MedicineResidency, Internal Medicine, 1985 - 1988- New York University School of MedicineClass of 1985
Certifications & Licensure
MD State Medical License 2016 - 2026
NY State Medical License 1986 - 2026- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1999
Publications & Presentations
PubMed
- 1 citationsSingle Monoclonal Antibodies Should Not Be Used for COVID-19 Therapy: A Call for Antiviral Stewardship.Arturo Casadevall, Daniele Focosi, Liise-Anne Pirofski, Shmuel Shoham
Clinical Infectious Diseases. 2024-12-17 - Lessons from the Use of Monoclonal Antibodies to SARS-CoV-2 Spike Protein During the COVID-19 Pandemic.Arturo Casadevall, Daniele Focosi
Annual Review of Medicine. 2024-12-04 - 3 citationsConvalescent plasma and predictors of mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis.Massimo Franchini, Mario Cruciani, Carlo Mengoli, Arturo Casadevall, Claudia Glingani
Clinical Microbiology and Infection. 2024-12-01
Journal Articles
- Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19Philippe R Bauer, Janis E Blair, Arturo Casadevall, The New England Journal of Medicine
Authored Content
- SARS-CoV-2 Viral Load and Antibody Responses: The Case for Convalescent Plasma TherapyJuly 2020
- SARS-CoV-2 Viral Load and Antibody Responses: The Case for Convalescent Plasma TherapyJuly 2020
Press Mentions
The Multipronged Problem of Candida AurisDecember 10th, 2024- Missed COVID Lifesaver: Johns Hopkins Reveals How Plasma Therapy Could Have Saved ThousandsOctober 9th, 2024
- Wider Use of Convalescent Plasma Might Have Saved Thousands More Lives During PandemicOctober 3rd, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
